WallStreetZenWallStreetZen

NASDAQ: ONCO
Onconetix Inc Stock

Overview
EarningsRevenueDividendOwnership
$2.77-0.18 (-6.1%)
Updated Aug 19, 2025
ONCO Price
$2.77
Fair Value Price
N/A
Market Cap
$4.28M
52 Week Low
$2.61
52 Week High
$577.32
P/E
0x
P/B
0.72x
P/S
2.04x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.33M
Earnings
-$44.18M
Gross Margin
66.4%
Operating Margin
-3,321.76%
Profit Margin
-3,458.2%
Debt to Equity
2.16
Operating Cash Flow
-$5M
Beta
0.75
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ONCO Overview

Blue Water Vaccines, Inc. is a biotechnology company developing vaccines for infectious diseases. The company's pipeline includes BWV-101, a flu vaccine, BWV-102, an H1 pre-pandemic vaccine, BWV-201, a streptococcus pneumoniae-induced acute otitis media vaccine, BWV-301, a norovirus-rotavirus vaccine, and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in Cincinnati, OH.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine ONCO's potential to beat the market

DSell
  • Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
View All “A” Zen Rated Stocks
→

Zen Rating Component Grades

D
Value
C
Growth
F
Momentum
C
Sentiment
F
Safety
D
Financials
F
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
ONCO
Ranked#286 of 482

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
Theravance Biopharma (TBPH)
$13.45A
Rigel Pharmaceuticals (RIGL)
$38.94A
Aurinia Pharmaceuticals (AUPH)
$12.03A
View Top Biotech Stocks

Be the first to know about important ONCO news, forecast changes, insider trades & much more!

ONCO News

Overview

Due Diligence Score

–
Industry Average (23)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ONCO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ONCO is good value based on its earnings relative to its share price (0x), compared to the US market average (35.19x)
P/E vs Market Valuation
ONCO is good value based on its earnings relative to its share price (0x), compared to the US Biotechnology industry average (-111.82x)
P/E vs Industry Valuation
ONCO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
There are 30 more ONCO due diligence checks available for Premium users.

Valuation

ONCO price to earnings (PE)

For valuing profitable companies with steady earnings

Company
0x
Industry
-111.82x
Market
35.19x
ONCO is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ONCO is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

ONCO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.72x
Industry
4.49x
ONCO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ONCO's financial health

Profit margin

Revenue
$106.5k
Net Income
-$2.4M
Profit Margin
-2,536.2%
ONCO's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ONCO's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$19.1M
Liabilities
$12.8M
Debt to equity
2.16
ONCO's short-term liabilities ($12.69M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ONCO's short-term assets ($930.53k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ONCO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.4M
Investing
$0.0
Financing
$744.6k
ONCO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ONCO vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
ONCOD$4.28M-6.10%0.00x0.72x
XBIO–$4.35M-3.99%-1.41x0.98x
JAGXD$4.18M-7.25%-0.03x0.52x
TOVX–$4.13M-2.27%-0.09x0.39x
GLTO–$4.46M0.00%-0.26x0.41x
View Top Biotech Stocks

Onconetix Stock FAQ

What is Onconetix's quote symbol?

(NASDAQ: ONCO) Onconetix trades on the NASDAQ under the ticker symbol ONCO. Onconetix stock quotes can also be displayed as NASDAQ: ONCO.

If you're new to stock investing, here's how to buy Onconetix stock.

What is the 52 week high and low for Onconetix (NASDAQ: ONCO)?

(NASDAQ: ONCO) Onconetix's 52-week high was $577.32, and its 52-week low was $2.61. It is currently -99.52% from its 52-week high and 6.13% from its 52-week low.

How much is Onconetix stock worth today?

(NASDAQ: ONCO) Onconetix currently has 1,545,704 outstanding shares. With Onconetix stock trading at $2.77 per share, the total value of Onconetix stock (market capitalization) is $4.28M.

Onconetix stock was originally listed at a price of $195,160.00 in Feb 18, 2022. If you had invested in Onconetix stock at $195,160.00, your return over the last 3 years would have been -100%, for an annualized return of -97.58% (not including any dividends or dividend reinvestments).

How much is Onconetix's stock price per share?

(NASDAQ: ONCO) Onconetix stock price per share is $2.77 today (as of Aug 19, 2025).

What is Onconetix's Market Cap?

(NASDAQ: ONCO) Onconetix's market cap is $4.28M, as of Aug 20, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Onconetix's market cap is calculated by multiplying ONCO's current stock price of $2.77 by ONCO's total outstanding shares of 1,545,704.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.